Manipulating regulatory T cells

Cytotherapy

Volumn 9, Issue 2, 2007, Pages 109-110

  Barrett, A J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RAPAMYCIN;

ADAPTIVE IMMUNITY; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; BLOOD AUTOTRANSFUSION; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIC PURPURA;

ANTIGENS, CD27; ANTIGENS, CD4; ANTIGENS, CD45; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; SIROLIMUS; T-LYMPHOCYTES, REGULATORY;

EID: 34047148430     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701217476     Document Type: Note

References (6)

1. Shevach, EM. (2006) From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity, 25, pp. 195-201.
2. Sakaguchi, S., Sakaguchi, N. and Asano, M.et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, pp. 1151-1164.
3. Taylor, PA, Lees, CJ and Blazar, BR. (2002) The infusion of ex vivo activated and expanded CD4(+), CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood, 99, pp. 3493-3499.
4. Rezvani, K., Mielke, S. and Ahmadzadeh, M.et al. (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood, 108, pp. 1291-1297.
5. Solomou, E., Rezvani, K. and Mielke, S. et al (2006) FOXP3-positive regulatory T cells in acquired aplastic anemia. Blood, 108, p. 636a.
6. Scheffold, A., Höhn, J. Höfer, T. (2005) Regulation of CD4+ CD25+ regulatory T cell activity: It takes (IL-) two to tango. Eur J Immunol, 35, pp. 1336-1341.